Abstract

BackgroundNasopharyngeal carcinoma (NPC), also known as Cantonese cancer, is rare worldwide, but has particularly high incidence in North Africa and Southeast Asia, especially in Guangdong, China, such as Guangzhou. Tobacco causes head and neck cancers, but nasopharyngeal carcinoma is not included as causally related to smoking in the 2014 United States Surgeon General’s report. Prospective evidence remains limited. We used Guangzhou Occupational Cohort data to conduct the first and robust prospective study on smoking and NPC mortality in an NPC high-risk region.MethodsInformation on demographic characteristics and smoking status was collected through occupational health examinations in factories and driver examination stations from March 1988 to December 1992. Vital status and causes of deaths were retrieved until the end of 1999. Cox proportional hazard model was used to assess the association of smoking with NPC mortality.ResultsOf 101,823 subjects included for the present analysis, 34 NPC deaths occurred during the average 7.3 years of follow up. The mean age (standard deviation) of the subjects was 41 (5.7) years. Compared with never smokers, the hazard ratio (HR) of NPC mortality was 2.95 (95 % confidence interval 1.01–8.68; p = 0.048) for daily smokers and 4.03 (1.29–12.58; p = 0.016) for smokers with more than 10 pack-years of cumulative consumption, after adjusting for age, sex, education, drinking status, occupation and cohort status and accounting for smoking-drinking interaction. The risk of NPC mortality increased significantly with cigarettes per day (p for trend = 0.01) and number of pack-years (p for trend = 0.02).ConclusionsIn this first and largest cohort in a high NPC risk region, smoking was associated with higher NPC mortality. The findings have shown statistically significant dose–response trend between smoking amount and smoking cumulative consumption and the risk of NPC mortality, but due to the small event number, further studies with larger sample size are needed to confirm the findings in the present study. Our results support that smoking is one of the risk factors likely to be causally associated with NPC mortality.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-015-1902-9) contains supplementary material, which is available to authorized users.

Highlights

  • Nasopharyngeal carcinoma (NPC), known as Cantonese cancer, is rare worldwide, but has high incidence in North Africa and Southeast Asia, especially in Guangdong, China, such as Guangzhou

  • Statistical methods Cox proportional hazard model was used in SPSS 20.0 to estimate hazards ratios (HRs) and 95 % confidence intervals (CIs) of NPC mortality for tobacco use adjusting for age, sex, education level, drinking status, occupation and cohort status

  • We showed that higher daily smoking amount and greater cumulative consumption being associated with higher risk of NPC mortality

Read more

Summary

Introduction

Nasopharyngeal carcinoma (NPC), known as Cantonese cancer, is rare worldwide, but has high incidence in North Africa and Southeast Asia, especially in Guangdong, China, such as Guangzhou. Tobacco causes head and neck cancers, but nasopharyngeal carcinoma is not included as causally related to smoking in the 2014 United States Surgeon General’s report. Nasopharyngeal carcinoma (NPC), known as Cantonese cancer, has a distinctive geographic variation [1,2,3] It is rare worldwide, but the incidence is high in North Africa and Southeast Asia, especially in Guangdong, China (for instance, Guangzhou City). Tobacco is classified as a group 1 carcinogen by the International Agency for Research on Cancer (IARC) It is a well-known causal factor for head and neck cancers, except NPC. The 2014 United States (US) Surgeon General Report [6] and the 2012 China Tobacco Hazard Report [7] were undecided on whether the association between smoking and NPC is causal

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call